LivaNova plc (LIVN) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
LivaNova Reports Fourth Quarter and Full-Year 2016 Results
March 1, 2017 7:02 AM ESTLONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today reported results for the fourth quarter and full year ended December 31, 2016.
For the fourth quarter of 2016, worldwide sales were $311 million, a decrease of 2.3 percent on a reported basis and a decrease of 1.6 percent on a constant-currency basis, as compared to the previous year. On a U.S. Generally Accepted Accounting Principles (GAAP) basis, fourth quarter 2016 loss per share was ($0.61). Fourth quarter 2016 adjusted diluted earnings per share were $0.85. For full-year 2016, worldwide sales were... More
